Broad immunomodulating effect of first-line pazopanib in metastatic renal cell carcinoma patients

Authors :: Darawan Rinchai
R. Montone
Paolo Grassi
L. De Cecco
Agata Cova
Davide Bedognetti
Raffaele Ratta
Giuseppe Procopio
Paola Squarcina
Elena Verzoni
Veronica Huber
M. Sorrentino
Licia Rivoltini
M. Dugo
Source :: ResearcherID
Publication Year :: 2017
Publisher :: Elsevier BV, 2017.

Subjects :: Pazopanib
Oncology
business.industry
Renal cell carcinoma
First line
Cancer research
Medicine
Hematology
business
medicine.disease
medicine.drug

Full Text Access

Tools